Quanta Announces IND Clearance by U.S. FDA for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates by Seini Moimoi | Jan 8, 2025 | Portfolio News
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc. by Seini Moimoi | Jan 8, 2025 | Portfolio News
Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials by Seini Moimoi | Jan 7, 2025 | Portfolio News
Epirium Bio Announces FDA Clearance of Investigational New Drug Application for MF-300 and Appointment of Alex Casdin as New Chief Executive Officer and Russell Cox as Executive Chairman by Seini Moimoi | Dec 23, 2024 | Portfolio News
BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions by Seini Moimoi | Dec 18, 2024 | Portfolio News
Veradermics Raises $75 Million in Series B Financing and Initiates Phase 2/3 Trial for Hair Loss by Seini Moimoi | Dec 11, 2024 | Portfolio News
